The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Evseev A.A.

Department of Obstetrics and Gynecology, Faculty of Pediatrics, Department of Immunology, N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia, Moscow, Russia

Shabrina O.V.

Pirogov Russian National Research Medical University, Moscow, Russia

Gavrilova E.A.

Pirogov Russian National Research Medical University, Moscow, Russia

Baykova M.K.

Pirogov Russian National Research Medical University, Moscow, Russia

Comparative evaluation of various methods of abortion in late terms

Authors:

Evseev A.A., Shabrina O.V., Gavrilova E.A., Baykova M.K.

More about the authors

Read: 12443 times


To cite this article:

Evseev AA, Shabrina OV, Gavrilova EA, Baykova MK. Comparative evaluation of various methods of abortion in late terms. Russian Bulletin of Obstetrician-Gynecologist. 2020;20(3):41‑48. (In Russ.)
https://doi.org/10.17116/rosakush20202003141

References:

  1. Maternal mortality in the Russian Federation in 2014. Letter of the Ministry of Health of the Russian Federation No. 15-4/10/2-5994 dated 10/9/2015. (In Russ.).
  2. Order of the Ministry of Health of the Russian Federation No. 572-n dated 11/1/2012 «Procedure for the provision of medical care in the profile of Obstetrics and Gynecology» (except for the use of assisted reproductive technologies). (In Russ.).
  3. Letter of the Ministry of Health of the Russian Federation dated December 4, 2018№15-4/10/2-7839. (In Russ.).
  4. Federal Law of the Russian Federation of November 21, 2011 №323-FL «On the Basics of Protecting the Health of Citizens in the Russian Federation». (In Russ.).
  5. Order of the Ministry of Health and Social Development of the Russian Federation of December 3, 2007 №736 «On approval of the list of medical indications for artificial termination of pregnancy». (In Russ.).
  6. Winikoff B, Dzuba IG, Chong E, Goldberg A. Extending outpatient medical abortion services through 70 days of gestational age. . 2012;120:5:1070-1076.
  7. Fiala C, Gemzell-Daniellson K. Review of medical abortion using mifepristone in combination with a prostaglandin analogue. . 2006;74:66-86.
  8. Best practice in comprehensive abortion care. Royal College of Obstetricians and Gynaecologists (RCOG). 2015. June.
  9. Safe abortion: technical and policy guidance for health systems. World Health Organization, Department of Reproductive Health and Research. 2012.
  10. ACOG. A Clinician’s Guide to Medical and surgical abortion. NAF’s textbook. 2012.
  11. Serov VN, Sukhikh GT.  Clinical recommendations. M.: GEOTAR-Media; 2015. (In Russ.).
  12. Dikke GB. Indications and current patterns of medical abortion. . 2017;108:7:35-40. (In Russ.).
  13. Kulier R, Kapp N, Gulmezoglu AM, Hofmeyr GJ.  2011.
  14. Dikke GB, Yarotskaya LV, Erofeeva LV. Strategic evaluation of policies, programs and services in the field of unplanned pregnancy, abortion and contraception in the Russian Federation. Joint study of the Ministry of Health and Social Development of the Russian Federation and WHO. . 2010;3: 92-108. (In Russ.).
  15. Medical abortion. Clinical recommendations. Moscow, 2015. Ministry of health of the Russian Federation No. 15-4/10/2-6120 dated 10/15/2015. (In Russ.).
  16. Paris AE, Vragovic O, Sonalkar E, Finneseth M, Borgatta L. Mifepristone and misoprostol compared to osmotic dilators for cervical preparation prior to surgical abortion at 15—18 weeks’ gestation: a randomised controlled non-inferiority trial. . 2019.
  17. Lerma K, Blumenthal PD. Current and potential methods for second trimester abortion. . 2019.
  18. Royal College of Obstetricians and Gynaecologists (RCOG). The care of women requesting induced abortion.
  19. Achilles SL, Reeves MF, Society of Family Planning. Prevention of infection after induced abortion: release date October 2010: SFP guideline 20102. . 2011;83:4:295-309.
  20. Serov VN. Hormonal contraception as a method of rehabilitation after abortion. . . 2010;2:26-28. (In Russ.).
  21. Avraham S, Gat I, Duvdevani N-R. Pre-emptive effect of ibuprofen versus placebo on pain relief and success rates of medical abortion: a double-blind, randomized, controlled study. . 2012;97:3:612-615. 
  22. Prilepskaya VN, Gus AI, Belousov DM, Kuzemin AA. Management tactics for women with suspected presence of residues of the fetal egg in the uterine cavity after medical abortion. . 2011;6:42-46. (In Russ.).
  23. Karapinar OS, Güngören A, Dolapçioğlu K. Does the presence of anhydramnios affect the duration of medical abortion? . 2016;87:9:635-638. 
  24. Oppegaard KS, Qvigstad E, Fiala C. Clinical follow-up compared with self-assessment of outcome after medical abortion: a multicentre, non-inferiority, randomised, controlled trial. . 2015;385:21:698-704. 
  25. Sinchikhin SP. Mifepristone in algorithms for drug abortion. Effective pharmacotherapy. . 2014;2:60-64. (In Russ.).
  26. Cleland K, Creinin MD, Nucatola D. Significant adverse events and outcomes after medical abortion. 2013;121:1:166-171.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.